Variable | Total | Vascular invasion | P value | Lymphatic invasion | P value |
---|---|---|---|---|---|
396 | Presence(%) | Presence(%) | |||
Gender | Â | Â | 0.437 | Â | 0.427 |
 Male | 290 | 78 (26.9) |  | 72 (24.8) |  |
 Female | 106 | 24 (22.6) |  | 22 (20.8) |  |
Age | Â | Â | 0.766 | Â | 0.759 |
 <65 years | 325 | 85 (26.2) |  | 76 (23.3) |  |
 ≥65 years | 71 | 17 (23.9) |  | 18 (25.4) |  |
Smoking status | Â | Â | 0.630 | Â | 0.537 |
 Non-smoker | 138 | 33 (23.9) |  | 30 (21.7) |  |
 Smoker | 258 | 69 (26.7) |  | 64 (24.8) |  |
Tumour location | Â | Â | 0.347 | Â | 0.671 |
 Upper | 35 | 7 (20.0) |  | 8 (22.9) |  |
 Middle | 253 | 62 (24.5) |  | 57 (22.5) |  |
 Lower | 108 | 33 (30.6) |  | 29 (26.9) |  |
Tumour length | Â | Â | 1.000 | Â | 0.637 |
 ≤4.0 cm | 199 | 51 (25.6) |  | 45 (22.6) |  |
 >4.0 cm | 197 | 51 (25.9) |  | 49 (24.9) |  |
Surgical approach | Â | Â | 1.000 | Â | 0.897 |
 Right incision | 118 | 30 (25.4) |  | 27 (22.9) |  |
 Left incision | 278 | 72 (25.9) |  | 67 (24.1) |  |
Differentiation | Â | Â | 0.274 | Â | 0.997 |
 G1 | 119 | 37 (31.1) |  | 28 (23.5) |  |
 G2 | 184 | 44 (23.9) |  | 44 (23.9) |  |
 G3 | 93 | 21 (22.6) |  | 22 (23.7) |  |
p T stage | Â | Â | 0.013 | Â | 0.376 |
 T1+T2 | 125 | 22 (17.6) |  | 26 (20.8) |  |
 T3+T4 | 271 | 80 (29.5) |  | 68 (25.1) |  |
p N stage | Â | Â | <0.001 | Â | <0.001 |
 N0 | 210 | 32 (15.2) |  | 33 (15.7) |  |
 N1+N2+N3 | 186 | 70 (37.6) |  | 61 (32.8) |  |
p TNM stage | Â | Â | <0.001 | Â | <0.001 |
 I stage | 49 | 4 (8.2) |  | 6 (12.2) |  |
 II stage | 164 | 29 (54.9) |  | 25 (15.2) |  |
 III stage | 170 | 60 (35.3) |  | 55 (32.4) |  |
 IV stage | 13 | 9 (69.2) |  | 8 (61.5) |  |
Relapse type | Â | Â | 0.816 | Â | 0.100 |
 Lymph node recurrence | 78 | 23 (29.5) |  | 25 (32.1) |  |
 Metastasis | 32 | 8 (25.0) |  | 5 (15.6) |  |